The iPLEDGE program will be updated in December to remove the Risk Evaluation and Mitigation Strategy pharmacy network connectivity. This means that pharmacies cannot get a Risk Management Authorization for isotretinoin through the switch. Beginning in December, pharmacies that dispense isotretinoin will only be able to get an RMA via the iPLEDGE Program website or the interactive voice response system. To learn more, attend an information session to review this change on July 29, at 2 p.m. ET. Register here.
NCPA
